Delivery Order SPE2DB22D3004-SPE2DB25FQ73G
- Not listed
- This federal contract award is for the delivery of HARVONI 90-400 MG 28S pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $96,940.02, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of July 11, 2016. There was no set-aside designation for this award. Amerisourcebergen...
- The Defense Logistics Agency Medical Supply Chain awarded a $5,979.96 delivery order to AmerisourceBergen Drug Corp for MAVYRET (sofosbuvir/velpatasvir) 100-40mg tablets, quantity 84 units, with a completion date of June 26, 2025. This competitive award, issued under a firm fixed-price contract type with no set-aside designation, represents a routine pharmaceutical procurement to support military healthcare operations. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a $11,825.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of 84 tablets of MAVYRET 100-40 mg. The contract, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a non-set-aside, competitively awarded procurement supporting federal medical supply requirements. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $7,602.85. The contract is for the delivery of sofosbuvir-velpatasvir 400-100 mg tablets, a treatment for chronic hepatitis C. The contract does not have a set-aside designation, indicating it was awarded on a full and open competition basis. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a larger pharmaceutical...
- The Defense Logistics Agency awarded a $3,914.81 delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on July 14, 2025, with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in hepatitis B treatment, representing part of the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $10,560.80 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $5,080.98 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on August 27, 2025, with completion scheduled for August 28, 2025. This non-set-aside, firm fixed-price delivery order represents a pharmaceutical procurement supporting federal medical supply needs. The award was issued to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $10,710.30 for Vemlidy 25 mg tablets (30-count units) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $4,041.59 delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on September 5, 2025, with completion targeted for September 8, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The place of performance is the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $1,252.42 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract involves no set-aside designation and is scheduled for completion by July 25, 2025,...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FQ73GDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,598.37 to AmerisourceBergen Drug Corp for HARVONI 90-400 mg tablets (28-count unit of use) on September 15, 2025, with completion targeted for September 16, 2025. This firm fixed-price, non-set-aside contract was awarded competitively and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. HARVONI is an antiviral medication used to treat hepatitis C and represents a specialized pharmaceutical product within the Defense Logistics Agency's medical supply portfolio. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products, medications, vaccines, and medical supplies to support military healthcare programs and the Defense Health Agency. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp has demonstrated capability to fulfill diverse federal healthcare requirements across multiple therapeutic domains through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 9/15/25 |